Additional file 1: Table S1. of Noonan syndrome and Turner syndrome patients respond similarly to 4 years’ growth-hormone therapy: longitudinal analysis of growth-hormone-naïve patients enrolled in the NordiNet® International Outcome Study and the ANSWER Program

Lee, Peter; Ross, Judith; Pedersen, Birgitte; Kotnik, Primoz; Germak, John; Christesen, Henrik

doi:10.6084/m9.figshare.c.3619061_D1.v1

13633_2015_15_MOESM1_ESM.doc (174.5 kB)

Additional file 1: Table S1. of Noonan syndrome and Turner syndrome patients respond similarly to 4 years’ growth-hormone therapy: longitudinal analysis of growth-hormone-naïve patients enrolled in the NordiNet® International Outcome Study and the ANSWER Program

journal contribution

posted on 2015-09-08, 05:00 authored by Peter Lee, Judith Ross, Birgitte Pedersen, Primoz Kotnik, John Germak, Henrik Christesen

Estimated means (unadjusted) of HSDS for Noonan syndrome and Turner syndrome patients per year. Table S2. Estimated means (unadjusted) of ΔHSDS for Noonan syndrome and Turner syndrome patients from baseline. Table S3. Change in IGF-I SDS over time. (DOC 174 kb)